Works matching DE "PATIENT safety"

Results: 5000
    1
    2
    3
    4

    ILOBONE: A phase I/IIa randomized controlled trial to assess the safety and feasibility of local iloprost therapy for enhancing proximal humerus fracture healing– a pilot study design.

    Published in:
    Journal of Orthopaedic Surgery & Research, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13018-025-05865-2
    By:
    • Elazaly, Hisham;
    • Dimitriou, Ioanna Maria;
    • Maleitzke, Tazio;
    • Dahne, Michael;
    • Jaecker, Vera;
    • Maerdian, Sven;
    • Tafelski, Sascha;
    • Diekhoff, Torsten;
    • Lindner, Tobias;
    • Akgün, Doruk;
    • Mielke, Anna-Maria;
    • Paksoy, Alp;
    • Amini, Dominik Adl;
    • Planatscher, Elisa Marie;
    • Leopold, Vincent;
    • González-Khatib, Susana;
    • Köhli, Paul Christoph;
    • Niemann, Marcel;
    • Hildebrandt, Alexander;
    • Oehme, Stephan
    Publication type:
    Article
    5
    6
    7
    8

    Position Statement of ISCCM on Intrahospital Transport of Critically Ill Patients.

    Published in:
    Indian Journal of Critical Care Medicine, 2025, v. 29, n. 4, p. 291, doi. 10.5005/jp-journals-10071-24939
    By:
    • Zirpe, Kapil G.;
    • Tiwari, Anand M.;
    • Kulkarni, Atul P.;
    • Govil, Deepak;
    • Samavedam, Srinivas;
    • Sharma, Jeetendra;
    • Dixit, Subhal B.;
    • Munjal, Manish;
    • Sinha, Sharmili;
    • Singh, Yogendra P.;
    • Sumalatha, Arunachala;
    • Kaurgayala, Swarna D.;
    • Chandankhede, Shweta R.;
    • Ahmed, Syed;
    • Bandyopadhyay, Susruta;
    • Karanth, Sunil;
    • Mishra, Vijay;
    • Dongre, Anand;
    • Gupta, Bikram;
    • Routray, Pragyan
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Leveraging real-world data from administrative claims and medical records to inform safety and effectiveness of piperacillin-tazobactam in the management of pediatric hospital–acquired pneumonia.

    Published in:
    American Journal of Epidemiology, 2025, v. 194, n. 5, p. 1426, doi. 10.1093/aje/kwae251
    By:
    • Blumenstock, Jesse A;
    • Faerber, Jennifer A;
    • Menon, Muida;
    • Lawler, Rasheeda;
    • Downes, Kevin J;
    • Kratz, Ellen;
    • Erickson, Kelley;
    • Haltzman-Cassenti, Brittany;
    • Yildirim, Inci;
    • Hussaini, Laila;
    • Elmontser, Mohnd;
    • Sederdahl, Bethany K;
    • Hahn, Andrea;
    • Thomson, Joanna;
    • Newland, Jason;
    • Terrill, Cindy;
    • Bradley, John;
    • Zachariah, Phillip;
    • Younus, Muhammad;
    • Mo, Jingping
    Publication type:
    Article
    21

    Barriers to initial COVID-19 booster among US adults who completed a primary vaccine series in the CHASING COVID cohort, September 2021–October 2022.

    Published in:
    American Journal of Epidemiology, 2025, v. 194, n. 5, p. 1341, doi. 10.1093/aje/kwae209
    By:
    • Rane, Madhura S;
    • Shen, Yanhan;
    • Robertson, Mc Kaylee;
    • Penrose, Kate;
    • Srivastava, Avantika;
    • Puzniak, Laura;
    • Allen, Kristen E;
    • Porter, Thomas M;
    • Kulkarni, Sarah;
    • You, William;
    • Berry, Amanda;
    • Parcesepe, Angela M;
    • Grov, Christian;
    • Zimba, Rebecca;
    • Nash, Denis
    Publication type:
    Article
    22
    23

    护理人力资源优化配置研究进展.

    Published in:
    Chinese Nursing Research, 2025, v. 39, n. 8, p. 1387, doi. 10.12102/j.issn.1009-6493.2025.08.024
    By:
    • 任宏飞;
    • 刘常清;
    • 柳亚茹;
    • 蒋艳;
    • 李幼平
    Publication type:
    Article
    24
    25
    26
    27
    28

    CURING THE INFODEMIC.

    Published in:
    Podiatrist, 2025, v. 28, n. 3, p. 26
    By:
    • Bennett, Emma
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis).

    Published in:
    Dermatology & Therapy, 2025, v. 15, n. 6, p. 1427, doi. 10.1007/s13555-025-01416-z
    By:
    • Valenti, Mario;
    • Ibba, Luciano;
    • Di Giulio, Sara;
    • Gargiulo, Luigi;
    • Malagoli, Piergiorgio;
    • Balato, Anna;
    • Bardazzi, Federico;
    • Loconsole, Francesco;
    • Burlando, Martina;
    • Cagni, Anna E.;
    • Cameli, Norma;
    • Carrera, Carlo G.;
    • Carugno, Andrea;
    • Cuccia, Aldo;
    • Dapavo, Paolo;
    • Di Brizzi, Eugenia V.;
    • Dini, Valentina;
    • Fargnoli, Maria C.;
    • Gaiani, Francesca M.;
    • Guarneri, Claudio
    Publication type:
    Article
    45

    Real-World Experience with FcRn Inhibitors Efgartigimod and Rozanolixizumab in Myasthenia Gravis: Administration in Multiple Cycles and Transition from Intravenous to Subcutaneous Formulation.

    Published in:
    Neurology & Therapy, 2025, v. 14, n. 3, p. 977, doi. 10.1007/s40120-025-00748-4
    By:
    • Yoshikawa, Masaaki;
    • Inoue, Yukako;
    • Tanaka, Koya;
    • Tsumura, Keisuke;
    • Hoshino, Yuki;
    • Shichijo, Chika;
    • Ide, Toshihiro;
    • Suzuyama, Kohei;
    • Iwasaki, Megumi;
    • Eriguchi, Makoto;
    • Yukitake, Motohiro;
    • Takashima, Hiroshi;
    • Koike, Haruki
    Publication type:
    Article
    46
    47
    48
    49
    50